08048036315
Premium Exporter of Genuine REXIGO 120mg Tablets from India to Singapore – Orchard | Phoenix Exim

1. General Information

REXIGO 120 mg Tablets contain Relugolix 120 mg, a medicine belonging to the class of gonadotropin-releasing hormone (GnRH) receptor antagonists. It is primarily used as hormonal therapy for advanced prostate cancer in adult men.

Relugolix works by rapidly reducing testosterone production. Since many prostate cancer cells depend on testosterone for growth, lowering testosterone can help slow the growth and progression of the disease.

REXIGO 120 mg is a prescription medicine and should be used only under the supervision of a qualified healthcare professional.

2. Product Information

  • Brand Name: REXIGO 120 mg Tablets
  • Active Ingredient: Relugolix
  • Strength: 120 mg
  • Dosage Form: Tablet
  • Therapeutic Class: GnRH receptor antagonist / hormonal anticancer therapy
  • Primary Indication: Advanced prostate cancer
  • Route: Oral
  • Manufacturer/Marketer: Zydus
  • Common Pack Information: 10 tablets per strip, depending on the marketed pack
  • Country of Origin: India

Product references list Rexigo 120 mg as containing relugolix 120 mg and identify Zydus as the manufacturer/marketer.

3. Uses of REXIGO 120 mg Tablets

REXIGO 120 mg is primarily used for the treatment of advanced prostate cancer in adult men.

It may be prescribed as part of androgen-deprivation or hormonal therapy when reducing testosterone is an important component of cancer management.

The exact treatment plan, duration, and combination with other cancer therapies should be determined by the treating oncologist.

4. Benefits of REXIGO 120 mg

The main therapeutic benefit of relugolix is its ability to reduce testosterone levels without requiring the same type of injectable androgen-deprivation therapy.

Potential treatment benefits include:

  • Helps reduce testosterone stimulation of prostate cancer cells.
  • May slow the growth and progression of advanced prostate cancer.
  • May help control hormone-sensitive prostate cancer.
  • Oral administration provides a tablet-based treatment option.
  • Rapid suppression of testosterone is an important pharmacological feature of relugolix.

These benefits should be understood as part of a medically supervised cancer-treatment plan rather than as a cure by itself.

5. Side Effects of REXIGO 120 mg

Like other prescription medicines, REXIGO 120 mg may cause side effects. Not every patient experiences them.

Reported or clinically relevant adverse effects can include:

  • Hot flushes
  • Fatigue
  • Musculoskeletal pain
  • Diarrhea
  • Constipation
  • Changes in glucose levels
  • Reduced hemoglobin
  • Muscle or joint discomfort
  • Changes in blood lipid levels
  • Abnormal liver-function test results

Most side effects may be manageable, but persistent, severe, or unusual symptoms should be discussed with the treating doctor.

6. Common Side Effects

Some commonly reported effects associated with Rexigo/relugolix therapy include:

  1. Hot flashes or sudden feelings of warmth
  2. Tiredness or fatigue
  3. Muscle and joint pain
  4. Constipation
  5. Diarrhea
  6. Changes in blood glucose
  7. Decreased hemoglobin
  8. Changes in cholesterol or other blood lipids

Patients should not stop cancer treatment on their own because of side effects. A doctor can determine whether treatment adjustment or supportive management is appropriate.

7. How to Use REXIGO 120 mg

Take REXIGO 120 mg exactly as prescribed by your doctor.

General administration information:

  • Take the tablet orally with water.
  • It may generally be taken with or without food.
  • Swallow the tablet whole.
  • Do not crush, chew, or break the tablet unless specifically instructed by your healthcare professional.
  • Take it consistently according to the prescribed schedule.
  • Do not change the dose or discontinue treatment without consulting your doctor.

If you miss a dose, follow your doctor's instructions or the product information supplied with your medicine rather than taking an extra dose on your own.

8. How REXIGO 120 mg Works

REXIGO contains relugolix, which blocks GnRH receptors.

Normally, GnRH signaling stimulates the hormonal pathway that ultimately promotes testosterone production. Relugolix blocks this signaling, resulting in a reduction in testosterone levels.

Because many prostate cancer cells use testosterone as a growth signal, reducing testosterone can help slow or inhibit the growth and progression of prostate cancer cells.

9. Safety Advice for REXIGO 120 mg

Because REXIGO is a prescription anticancer medicine, appropriate medical supervision is important.

Before taking REXIGO

Tell your doctor if you:

  • Have a history of heart disease or cardiovascular problems.
  • Have liver or other significant medical conditions.
  • Take prescription, non-prescription, or herbal medicines.
  • Have experienced an allergy to relugolix or any component of the medicine.
  • Have a partner who is pregnant or may become pregnant.

Relugolix can interact with other medicines, and some medicines may affect its effectiveness. Your healthcare provider should review your complete medication list.

Heart-related precautions

Relugolix treatment may require consideration of heart-rhythm risks. Seek urgent medical attention for symptoms such as fainting, significant palpitations, severe dizziness, or chest pain.

Pregnancy

REXIGO is intended for the treatment of prostate cancer in adult men. Men with partners who could become pregnant should discuss appropriate contraception with their doctor during treatment.

Driving and machinery

If you experience significant fatigue, weakness, dizziness, or sleepiness, avoid driving or operating machinery until you know how the medicine affects you.

Monitoring

Your doctor may recommend regular clinical and laboratory monitoring to assess your response and monitor for adverse effects.

10. Frequently Asked Questions (FAQs)

Q1. What is REXIGO 120 mg used for?

REXIGO 120 mg contains relugolix and is primarily used to treat advanced prostate cancer in adult men.

Q2. What is the active ingredient in REXIGO 120 mg?

The active ingredient is Relugolix 120 mg.

Q3. How does REXIGO 120 mg work?

It blocks GnRH receptors and reduces testosterone production. Lower testosterone can reduce hormonal stimulation of prostate cancer cells.

Q4. Can REXIGO 120 mg be taken with food?

Yes. Available product information states that it can generally be taken with or without food.

Q5. Can I stop REXIGO when I feel better?

No. Do not stop or change your cancer treatment without consulting your oncologist.

Q6. Does REXIGO 120 mg have side effects?

Yes. Possible effects include hot flashes, fatigue, musculoskeletal pain, constipation, diarrhea, changes in glucose, and decreased hemoglobin.

Q7. Is REXIGO 120 mg a prescription medicine?

Yes. It is listed as a prescription medicine and should be taken under medical supervision.

Q8. What should I do if I miss a dose?

Follow the missed-dose instructions provided by your doctor or the official product information. Do not double the next dose unless specifically instructed.

Q9. Can REXIGO interact with other medicines?

Yes. Other medicines can affect relugolix or its effectiveness. Inform your doctor about all medicines and supplements you are taking.

Q10. Who should I contact about changing from REXIGO to another medicine?

Speak with your oncologist or qualified healthcare professional. Substitution should be based on the active ingredient, strength, indication, medical history, and treatment plan.

11. Substitute for REXIGO 120 mg

Several medicines containing relugolix 120 mg are listed as alternatives/substitutes in Indian pharmaceutical references. Examples include:

  • Orgonist 120 mg Tablet
  • Reglid 120 mg Tablet
  • Reluvyx 120 mg Tablet
  • Roarlix 120 Tablet

Availability, manufacturer, formulation, and regulatory status can vary by country. These products should not be substituted automatically. A doctor or pharmacist should confirm that the alternative is appropriate before changing treatment.

12. SEO Keywords

Primary Keywords

  • Rexigo 120 mg Tablets
  • Rexigo 120 mg Tablet exporter
  • Rexigo 120 mg supplier from India
  • Rexigo 120 mg pharmaceutical exporter
  • Relugolix 120 mg Tablets
  • Relugolix 120 mg exporter
  • Relugolix 120 mg supplier India
  • Rexigo 120 mg medicine supplier

Long-Tail B2B Keywords

  • Buy Rexigo 120 mg Tablets from India
  • Rexigo 120 mg Tablets exporter from Nagpur India
  • Relugolix 120 mg pharmaceutical supplier from India
  • Rexigo 120 mg Tablets wholesale supplier India
  • Rexigo 120 mg medicine exporter to USA
  • Rexigo 120 mg medicine exporter to UK
  • Rexigo 120 mg supplier to Australia
  • Rexigo 120 mg exporter to Singapore
  • Rexigo 120 mg pharmaceutical supplier to Canada
  • Rexigo 120 mg exporter to South Korea
  • Rexigo 120 mg medicine supplier to UAE
  • Relugolix 120 mg tablets supplier from India
  • Advanced prostate cancer medicine supplier India
  • Relugolix 120 mg oncology medicine exporter
  • Rexigo 120 mg genuine pharmaceutical supplier
  • Rexigo 120 mg tablets international supplier
  • Rexigo 120 mg oncology medicine exporter from India
  • Relugolix 120 mg wholesale pharmaceutical exporter
  • Rexigo 120 mg tablets for prostate cancer treatment
  • Indian pharmaceutical exporter for oncology medicines

Phoenix Exim SEO Keywords

  • Phoenix Exim Rexigo 120 mg supplier
  • Phoenix Exim Relugolix 120 mg exporter
  • Phoenix Exim pharmaceutical exporter Nagpur
  • Rexigo 120 mg exporter from Nagpur India
  • Phoenix Exim oncology medicine exporter India
  • Rexigo 120 mg international medicine supplier
  • Relugolix 120 mg exporter from India to USA UK Australia
  • Rexigo 120 mg supplier India to Singapore Canada UAE
  • Rexigo 120 mg pharmaceutical exporter to South Korea
  • Trusted Indian pharmaceutical exporter for Rexigo 120 mg
Aug 20th, 2026 3:13 PM

Keywords